Authors

• Scott Floyd (ORCID: https://orcid.org/0000-0002-8067-2426)
• Sebastian Winter (ORCID: https://orcid.org/0000-0001-8836-0235)
• Chunhao Wang (ORCID: https://orcid.org/0000-0002-6945-7119)
• R.F. Shenker (ORCID: https://orcid.org/0000-0001-6552-6255)
• Karen Allen
• Peter G. Hendrickson (ORCID: https://orcid.org/0000-0002-3068-9350)
• Trey C. Mullikin (ORCID: https://orcid.org/0000-0002-1099-1763)
• Zachary J. Reitman (ORCID: https://orcid.org/0000-0002-9122-9550)
• Paul W. Sperduto (ORCID: https://orcid.org/0000-0002-4628-7161)
• Helen Alice Shih (ORCID: https://orcid.org/0000-0003-1550-9726)
• Jörg Dietrich (ORCID: https://orcid.org/0000-0001-8291-0136)
• Zihan Wan (ORCID: https://orcid.org/0009-0005-9359-6417)
• Warren Floyd (ORCID: https://orcid.org/0000-0003-4371-8453)
• Jeffrey Clarke (ORCID: https://orcid.org/0000-0001-5647-0245)
• Donna Niedzwiecki (ORCID: https://orcid.org/0000-0002-3566-0450)
• Eugene Vaios (ORCID: https://orcid.org/0000-0003-2122-6650)
• David Carpenter (ORCID: https://orcid.org/0000-0002-9261-7168)
• John P. Kirkpatrick (ORCID: https://orcid.org/0000-0002-4019-0350)
• April K.S. Salama (ORCID: https://orcid.org/0000-0002-8105-5374)

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• Duke University (US)
• Massachusetts General Hospital (US)
• Duke Medical Center (US)
• Duke University Hospital (US)

Publication Details

Journal

JAMA Network Open

Published

2025-04-09

DOI

https://doi.org/10.1001/jamanetworkopen.2025.4347

Citations

14

Primary Topic

Brain Metastases and Treatment

Type

article

Field-Weighted Citation Impact

21.26

Funders

• Amgen
• Bristol-Myers Squibb
• Pfizer
• Regeneron Pharmaceuticals
• National Institutes of Health
• National Cancer Institute
• Janssen Pharmaceuticals
• Duke Cancer Institute